A Highly Specific Substrate for NanoLUC Luciferase Furimazine Is Toxic in vitro and in vivo

V. O. Shipunova, O. N. Shilova, E. I. Shramova, S. M. Deyev, G. M. Proshkina

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

The bioluminescent platform based on a genetically engineered luciferase NanoLuc and its synthetic substrate furimazine is widely used in modern molecular biology for optical imaging and therapy of deep tissue tumors. Taking into account the perspectives of using this system in molecular biology research, a detailed study of the toxicity of furimazine in vitro and in vivo is of great interest. In this work, the cytotoxicity of furimazine in vitro was studied using four different cell lines. Systemic toxicity of furimazine in vivo was investigated under conditions of prolonged administration of the substrate in animals. It has been found that seven-day intravenous injection of the substrate in animals causes hydropic dystrophy of liver and necrosis of hepatocytes. Splitting of the dose into several injections reduces hepatotoxicity of furimazine.

Original languageEnglish
Pages (from-to)225-228
Number of pages4
JournalRussian Journal of Bioorganic Chemistry
Volume44
Issue number2
DOIs
Publication statusPublished - 1 Mar 2018
Externally publishedYes

Keywords

  • furimazine
  • hepatotoxicity
  • NanoLuc luciferase

ASJC Scopus subject areas

  • Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'A Highly Specific Substrate for NanoLUC Luciferase Furimazine Is Toxic in vitro and in vivo'. Together they form a unique fingerprint.

Cite this